Neuromuscular blocking and autonomic effects of vecuronium and atracurium in the anaesthetized cat.

The effects of vecuronium and atracurium on neuromuscular transmission, on the responses of the heart rate to vagal stimulation and on the responses to preganglionic stimulation of the nictitating membrane were compared in the chloralose-anaesthetized cat. Vecuronium was four times more potent than atracurium as a neuromuscular blocking agent, whereas the two compounds had similar potencies in blocking the effects of stimulation of the cardiac vagus. The vagal/neuromuscular ratios measured at 50% inhibition were 96 for vecuronium and 25 for atracurium. Vecuronium possessed a slightly shorter recovery time than atracurium and shorter duration of action on the soleus muscle. The onset times of the two compounds were not significantly different. Both compounds had longer time-courses of action than suxamethonium. Very large doses of vecuronium decreased the responses of the preganglionic stimulation of the nictitating membrane, suggesting that at high doses the compound possesses ganglion blocking activity. Large doses of atracurium also decrease the nictitating membrane responses and, in some cats, contractions of the nictitating membrane associated with increases in heart rate and arterial pressure were observed.

[1]  I. G. Marshall,et al.  Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat. , 1983, British journal of anaesthesia.

[2]  H. H. Ali,et al.  Clinical Pharmacology of Atracurium Besylate (BW 33A): A New Non‐depolarizing Muscle Relaxant , 1982, Anesthesia and analgesia.

[3]  R. Katz,et al.  Neuromuscular Effects of Atracurium in Man , 1982, Anesthesia and analgesia.

[4]  P. Lilleaasen,et al.  Dose-response relation for atracurium, ORG NC 45 and pancuronium. , 1982, British journal of anaesthesia.

[5]  R. Miller,et al.  Clinical Pharmacology of ORG NC45 (NorcuronTM): A New Nondepolarizing Muscle Relaxant , 1981, Anesthesiology.

[6]  J. P. Payne,et al.  A Preliminary Assessment of Atracurium, a New Competitive Neuromuscular Blocking Agent , 1981, Acta Anaesthesiologica Scandinavica.

[7]  J. P. Payne,et al.  Evaluation of atracurium in anaesthetized man. , 1981, British journal of anaesthesia.

[8]  R. Hughes,et al.  The pharmacology of atracurium: a new competitive neuromuscular blocking agent. , 1981, British journal of anaesthesia.

[9]  N. Krieg,et al.  RELATIVE POTENCY OF ORG NC 45, PANCURONIUM, ALCURONIUM AND TUBOCURARINE IN ANAESTHETIZED MAN , 1980 .

[10]  L. Booij,et al.  First clinical experiences with ORG NC 45. , 1980, British journal of anaesthesia.

[11]  I. G. Marshall,et al.  The neuromuscular and autonomic blocking activities of pancuronium, Org NC 45, and other pancuronium analogues, in the cat , 1979, The Journal of pharmacy and pharmacology.

[12]  R. Hughes,et al.  Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetized cats and rhesus monkeys. , 1976, British journal of anaesthesia.